IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rexahn Pharmaceuticals Inc

CUSIP: 761640101 | 81 institutional holders

Quarters

Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2018

Orange Investment Advisors, Inc.20,000
0.0% of portfolio›$36
StyleTurnoverLocationFiled
Orange Investment Advisors, Inc.
20,000$360.0%CoreLowGoshen, NY2018-10-12